Avicanna Inc

STU:0NN (Canada)   Ordinary Shares
€ 0.22 (+9%) Dec 20
At Loss
P/B:
20.00
Market Cap:
€ 23.38M ($ 24.38M)
Enterprise V:
€ 28.00M ($ 29.19M)
Volume:
-
Avg Vol (2M):
8.00K
Trade In:

Business Description

Description
Avicanna Inc is an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products for the global consumer, as well as medical and pharmaceutical market segments. In global cannabinoid advancements, it conducts most of its research in Canada at its research and development headquarters in JLABS in Toronto, located in the MaRS Discovery District. The company actively collaborates with Canadian academic and medical institutions. Avicanna has established a scientific platform including research and development and clinical development which led to the commercialization of more than twenty products across four main market segments.
Name Current Vs Industry Vs History
Cash-To-Debt 3.55
Equity-to-Asset 0.08
Debt-to-Equity 0.13
Debt-to-EBITDA -0.04
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.02
Distress
Grey
Safe
Beneish M-Score -3.05
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 52.53
9-Day RSI 52.75
14-Day RSI 52.88
6-1 Month Momentum % -6.98

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.83
Quick Ratio 0.43
Cash Ratio 0.08
Days Inventory 115.72
Days Sales Outstanding 45.57
Days Payable 216.21

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -36.2
Shareholder Yield % -8.97
Name Current Vs Industry Vs History
Gross Margin % 44.86
Operating Margin % -25.15
Net Margin % -27.31
FCF Margin % -13.29
ROE % -1580.66
ROA % -31.47
ROIC % -39.84
ROC (Joel Greenblatt) % -53.96
ROCE % -66.65

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 1.22
PB Ratio 20
EV-to-EBIT -6.63
EV-to-EBITDA -7.72
EV-to-Revenue 1.69
EV-to-FCF -12.71
Earnings Yield (Greenblatt) % -15.08
FCF Yield % -9.41

Financials

STU:0NN's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Avicanna Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 16.842
EPS (TTM) (€) -0.07
Beta 0
Volatility % 0
14-Day RSI 52.88
14-Day ATR (€) 0.022193
20-Day SMA (€) 0.21105
12-1 Month Momentum % 0
52-Week Range (€) 0.139 - 0.34
Shares Outstanding (Mil) 109.57

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Avicanna Inc Filings

Filing Date Document Date Form
No Filing Data

Avicanna Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Avicanna Inc Frequently Asked Questions

What is Avicanna Inc(STU:0NN)'s stock price today?
The current price of STU:0NN is €0.22. The 52 week high of STU:0NN is €0.34 and 52 week low is €0.14.
When is next earnings date of Avicanna Inc(STU:0NN)?
The next earnings date of Avicanna Inc(STU:0NN) is .
Does Avicanna Inc(STU:0NN) pay dividends? If so, how much?
Avicanna Inc(STU:0NN) does not pay dividend.

Press Release

Subject Date
No Press Release